In the equine athlete, single or repetitive episodes of trauma to the synovial membrane and fibrous joint capsule commonly result in
inflammatory synovitis and capsulitis. Inflammatory mediators resulting from synovitis can cause biochemical damage that leads to
degradation of articular cartilage, resulting in osteoarthritis (OA).
1
OA is defined as the progressive deterioration of articular cartilage
accompanied by changes in bone and soft tissue.
1
The ongoing pain and inflammation associated with development of OA can be
career-limiting for athletic horses required to perform at a high level. In the medical management of OA by equine practitioners,
intra-articular corticosteroids are considered a cornerstone of therapy to reduce inflammation.
(betamethasone sodium phosphate and
betamethasone acetate injectable suspension)
BetaVet
®
(betamethasone sodium phosphate and betamethasone acetate injectable suspension)
For Intra-articular (I.A.) use in Horses.
INDICATION: BetaVet
®
(betamethasone sodium phosphate and betamethasone acetate injectable suspension) is indicated for the
control of pain and inflammation associated with osteoarthritis in horses.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS: BetaVet
®
is contraindicated in horses with hypersensitivity to betamethasone. Intra-articular injection of
corticosteroids for local effect is contraindicated in the presence of septic arthritis.
(continued on next page)
By Marian R. Graves, DVM, Technical Veterinarian, Medical Affairs, American Regent, Inc. Some content may reflect medical opinion.
Equine
Technical
Bulletin
BetaVet
®
Use in
Equine Athletes
